Nanoarchitectures to Deliver Nucleic Acid Drugs to Disease Sites

Abstract: Therapeutic nucleic acid drugs (antisense DNA, siRNA, DNAzyme, and others) have been widely employed to regulate the expression of a disease‐causing gene. For the correction of a gene, the CRISPR/Cas9 system is available. Advantageously, they can be straightforwardly designed in terms of the Watson‐Crick rule. In order to deliver these nucleic acid drugs to a target place in our body (organs and cells) at desired timing, various nanoarchitectures have been elegantly designed. Their primary roles are protection of drugs from degradation, increase of cell‐membrane permeability, and spatiotemporal control of delivery. Encapsulated nucleic acid drugs are released by decomposing the nanostructures with either external stimuli or intracellular signals. Furthermore, therapeutic efficiency is enhanced by simultaneously delivering multiple types of nucleic acid drugs for their cooperation. Composites of nanoarchitectures and therapeutic nucleic acid drugs are highly promising for future applications.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Nanoarchitectures to Deliver Nucleic Acid Drugs to Disease Sites ; day:19 ; month:04 ; year:2023 ; extent:14
ChemNanoMat ; (19.04.2023) (gesamt 14)

Creator
Komiyama, Makoto
Sumaoka, Jun

DOI
10.1002/cnma.202300069
URN
urn:nbn:de:101:1-2023042415292874449153
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Komiyama, Makoto
  • Sumaoka, Jun

Other Objects (12)